|
Home | Medical-Newswire.Com:
|
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, 'Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016', provides in depth analysis on Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2016SummaryPublisher's, 'Beta Secretase 1 (Aspartyl Protease...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, 'Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016', provides in depth analysis on Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, 'Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016', provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targeted pipeline therapeutics. The report provides comprehensive information on the Angiopoietin 2 (Ang 2 or ANGPT2),...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, '72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2016', provides in depth analysis on 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, '70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016', provides in depth analysis on 70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) targeted pipeline therapeutics. The report provides comprehensive...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, '65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) - Pipeline Review, H1 2016', provides in depth analysis on 65 kDa Phosphoprotein (PP65 or Tegument Protein UL83, Cytomegalovirus) targeted pipeline therapeutics. The report...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, '5'-Nucleotidase (CD73 or Ecto-5'-Nucleotidase or EC 3.1.3.5) - Pipeline Review, H1 2016', provides in depth analysis on 5'-Nucleotidase (CD73 or Ecto-5'-Nucleotidase or EC 3.1.3.5) targeted pipeline therapeutics. The report provides comprehensive...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) DelveInsight's, "Vasopressin Receptor Antagonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vasopressin Receptor Antagonists. The DelveInsight's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, "Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vascular Endothelial Growth Factor D (VEGF-D) Inhibitors....
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, "Toll-Like Receptor 4 (TLR-4) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Toll-Like Receptor 4 (TLR-4) Agonists. The Publisher's Report covers the product...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, "Sphingosine 1-Phosphate (S1P) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Sphingosine 1-Phosphate (S1P) Inhibitors. The Publisher's Report covers the...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, "Sodium-Potassium ATPase (Na+/K+-exchanging ATPase or Sodium-Potassium Pump or Sodium pump) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Sodium-Potassium...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) Publisher's, "Ribosome Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Ribosome Inhibitors. The Publisher's Report covers the product profiles in various stages of development...
Source: EmailWire.com
 (Medical-NewsWire.com, October 28, 2016 ) DelveInsight's, "Retinoid x receptors Gamma (RXRs) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Retinoid x receptors Gamma (RXRs) Agonists. The DelveInsight's Report...
Source: EmailWire.com
|
|
|
|
